FDA Warning Letter — Gulf Pharmaceutical Industries - Julphar
The FDA took a Warning Letter action against Gulf Pharmaceutical Industries - Julphar on February 23, 2012 (Ras Al Khaimah, United Arab Emirates). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Gulf Pharmaceutical Industries - Julphar
- Date
- February 23, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Center
- CDER
- Location
- Ras Al Khaimah (United Arab Emirates)